Attached files
| file | filename |
|---|---|
| EX-21.1 - EXHIBIT 21.1 - ROCK CREEK PHARMACEUTICALS, INC. | v433617_ex21-1.htm |
| EX-32.1 - EXHIBIT 32.1 - ROCK CREEK PHARMACEUTICALS, INC. | v433617_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - ROCK CREEK PHARMACEUTICALS, INC. | v433617_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ROCK CREEK PHARMACEUTICALS, INC. | v433617_ex31-2.htm |
| 10-K - FORM 10-K - ROCK CREEK PHARMACEUTICALS, INC. | v433617_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - ROCK CREEK PHARMACEUTICALS, INC. | v433617_ex32-2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Rock Creek Pharmaceuticals, Inc. and Subsidiaries
We hereby consent to the incorporation by reference in the Registration Statement on Form S-1 (No. 333-208016), the Registration Statements on Form S-8 (Nos. 333-121728, 333-155642, 333-194877, and 333-200966) and the Registration Statements on Form S-3 (Nos. 333-115293, 333-118054, 333-124400, 333-129689, 333-134222, 333-136576, 333-145342, 333-150071, 333-151161, 333-158288, 333-162341, 333-166166, 333-171121, 333-173627, 333-182077, 333-196540, 333-200964, 333-202131, and 333-204065) of our report dated March 22, 2016 relating to the Rock Creek Pharmaceuticals, Inc. and Subsidiaries consolidated financial statements as of December 31, 2015 and 2014.
/s/ Cherry Bekaert LLP
Tampa, Florida
March 22, 2016